Clinical Trial Update: Next DPI LABA, Multicentre, 5-way Cross-over, Adult Asthmatic Patients [Phase 2]

View source ↗

Summary

The document reports completion of a multicenter Phase 2 crossover trial evaluating a next-generation dry powder inhaler long-acting beta-agonist (LABA) in adul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Next DPI LABA (investigational)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma | Phase 2 | Status: COMPLETED